Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel fibrinogen antagonist from Merck & Co.

June 11, 1997

Thrombin inhibitors revealed by Merck & Co.

June 10, 1997

Merck & Co. fibrinogen antagonist characterized in animals

June 9, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

First launch for lepirudin

June 5, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Astra shifts focus to newer thrombin inhibitor

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

Nissan Chem. reveals antiplatelet agents

May 29, 1997

Neutralase effective for heparin reversal in CAB

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...